Viatris (VTRS -0.29%下跌) 已同意以16.5亿美元收购止痛药制造商 Pacira BioSciences (PCRX 1.78%上涨)，此次交易将扩大这家医疗公司的药物组合。
Viatris VTRS -0.29%decrease; down pointing triangle has agreed to buy pain-drug maker Pacira BioSciences PCRX 1.78%increase; up pointing triangle for $1.65 billion in a deal that expands the healthcare company’s medicines portfolio.
Viatris 周四表示，将以每股36.50美元现金收购 Pacira，较周三收盘价25.20美元溢价约45%，Pacira 总部位于加利福尼亚州布里斯班。
Viatris on Thursday said it would pay $36.50 a share in cash for Pacira, a roughly 45% premium to Wednesday’s closing price of $25.20 for the Brisbane, Calif., company.